Crimean-Congo Haemorrhagic Fever

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Crimean-Congo Haemorrhagic Fever trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT06799013

Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

The goal of this clinical trial is to assess the safety, tolerability and immunogenicity of three dosage levels, and a single or two-dose administration regimen…

United States48 participantsStarted 2025-07-10

Treatment: 10 ug HDT 321, 25ug HDT-321

All recent trials (9 shown)

CompletedPhase 1

NCT06684431

Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 Against Crimean Congo Hemorrhagic Fever

This First-in-human dose-escalation vaccine phase I study aims to evaluate safety and reactogenicity of the investigational vaccine N-pVAX1, against Crimean Con…

Sweden15 participantsStarted 2024-11-12

Treatment: N-pVAX1

Not Yet RecruitingNot Applicable

NCT06624787

Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care

The goal of this medical device diagnostic evaluation study is to determine if this novel lateral flow device can detect Crimean-Congo Hemorrhagic Fever (CCHF)…

Location not specified492 participantsStarted 2026-04

Treatment: Rapid Diagnostic Test

Crimean-Congo Haemorrhagic Fever

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

All recent trials (9 shown)

Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 Against Crimean Congo Hemorrhagic Fever

Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

All recent trials (9 shown)

Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 Against Crimean Congo Hemorrhagic Fever

Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care

Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever

Development of a Rapid Diagnostic Test to Identify Crimean-Congo Hemorrhagic Fever - Research and Development Testing

UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF

Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Disea…

Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities

Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimea…